Work

Serum androgens and survival in metastatic castration resistant prostate cancer (mCRPC) patients treated with docetaxel and prednisone: Results from CALGB 90401 (Alliance).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.5067

Authors: Charles J. Ryan, Sandipan Dutta, William Kevin Kelly, Rob Middleberg, Carly Russell, Eric Jay Small, Michael J. Morris, Mary-Ellen Taplin, Susan Halabi

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Duke University, Thomas Jefferson University, Sidney Kimmel Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Duke Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890930343

Cites:

Cited by:

Related to: 10